Literature DB >> 19552643

Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital.

Quique Bassat1, Caterina Guinovart, Betuel Sigaúque, Inácio Mandomando, Pedro Aide, Jahit Sacarlal, Tacilta Nhampossa, Azucena Bardají, Luís Morais, Sonia Machevo, Emilio Letang, Eusébio Macete, John J Aponte, Anna Roca, Clara Menéndez, Pedro L Alonso.   

Abstract

OBJECTIVES: To describe the prevalence, aetiology and prognostic implications of coexisting invasive bacterial disease in children admitted with severe malaria in a rural Mozambican Hospital.
METHODS: Retrospective study of data systematically collected from June 2003 to May 2007 in a rural Mozambican hospital, from all children younger than 5 years admitted with severe malaria.
RESULTS: Seven thousand and forty-three children were admitted with a diagnosis of malaria. 25.2% fulfilled the criteria for severe malaria. 5.4% of the children with severe malaria and valid blood culture results had a concomitant bacteraemia. Case fatality rates of severe malaria cases rose steeply when bacteraemia was also present (from 4.0% to 22.0%, P < 0.0001), and bacteraemia was an independent risk factor for death among severe malaria patients (adjusted OR 6.2, 95% CI 2.8-13.7, P = 0.0001). Streptococcus pneumoniae, Gram-negative bacteria, Staphilococcus aureus and non-typhoid Salmonella (NTS) were the most frequently isolated microorganisms among severe malaria cases. Their frequency and associated case fatality rates (CFR) varied according to age and to syndromic presentation. Streptococcus pneumoniae had a relatively low CFR, but was consistently associated with severe malaria syndromes, or anaemia severity groups. No clear-cut relationship between malarial anaemia and NTS bacteraemia was found.
CONCLUSIONS: The coexistence of malaria and invasive bacterial infections is a frequent and life-threatening condition in many endemic African settings. In Mozambique, S. pneumoniae is the leading pathogen in this interaction, possibly as a consequence of the high HIV prevalence in the area. Measures directed at reducing the burden of both those infections are urgently needed to reduce child mortality in Africa.

Entities:  

Mesh:

Year:  2009        PMID: 19552643     DOI: 10.1111/j.1365-3156.2009.02326.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  57 in total

Review 1.  Do multiple concurrent infections in African children cause irreversible immunological damage?

Authors:  Sarah J Glennie; Moffat Nyirenda; Neil A Williams; Robert S Heyderman
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 2.  Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.

Authors:  Christy An Okoromah; Bosede B Afolabi; Emma Cb Wall
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

3.  Modulation of the immune and inflammatory responses by Plasmodium falciparum schizont extracts: role of myeloid dendritic cells in effector and regulatory functions of CD4+ lymphocytes.

Authors:  Ann Maria Clemente; Giulia Fadigati; Roberto Caporale; Damiano G Marchese; Giuseppe Castronovo; Anna Rosa Sannella; Carlo Severini; Federica Verra; Enrico Garaci; Federico Cozzolino; Maria Gabriella Torcia
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

4.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

5.  Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania.

Authors:  Holly M Biggs; Rebecca Lester; Behzad Nadjm; George Mtove; Jim E Todd; Grace D Kinabo; Rune Philemon; Ben Amos; Anne B Morrissey; Hugh Reyburn; John A Crump
Journal:  Clin Infect Dis       Date:  2013-12-13       Impact factor: 9.079

6.  Bacterial coinfections in travelers with malaria: rationale for antibiotic therapy.

Authors:  Johanna Sandlund; Pontus Naucler; Saduddin Dashti; Akhar Shokri; Sara Eriksson; Marika Hjertqvist; Lillemor Karlsson; Teodor Capraru; Anna Färnert
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

7.  Feasibility of flow cytometry for measurements of Plasmodium falciparum parasite burden in studies in areas of malaria endemicity by use of bidimensional assessment of YOYO-1 and autofluorescence.

Authors:  Joseph J Campo; John J Aponte; Augusto J Nhabomba; Jahit Sacarlal; Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Pedro L Alonso; Carlota Dobaño
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

8.  Distinguishing malaria from severe pneumonia among hospitalized children who fulfilled integrated management of childhood illness criteria for both diseases: a hospital-based study in Mozambique.

Authors:  Quique Bassat; Sónia Machevo; Cristina O'Callaghan-Gordo; Betuel Sigaúque; Luís Morais; Núria Díez-Padrisa; Josep L Ribó; Inácio Mandomando; Tacilta Nhampossa; Edgar Ayala; Sergi Sanz; Martin Weber; Anna Roca; Pedro L Alonso
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

9.  Bacteremia in Kenyan children presenting with malaria.

Authors:  T Were; G C Davenport; J B Hittner; C Ouma; J M Vulule; J M Ong'echa; D J Perkins
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

10.  WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study.

Authors:  Behzad Nadjm; Ben Amos; George Mtove; Jan Ostermann; Semkini Chonya; Hannah Wangai; Juma Kimera; Walii Msuya; Frank Mtei; Denise Dekker; Rajabu Malahiyo; Raimos Olomi; John A Crump; Christopher J M Whitty; Hugh Reyburn
Journal:  BMJ       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.